Chatham-Kent Clinical Trials /ID# 235707

Chatham, Ontario N7L 1C1

0 studies enrolling now · 1 studies all time

What they study most

Major Depressive Disorder

Studies at this site

• The Objective of This Study is to Evaluate the Efficacy, Safety and Tolerability of Cariprazine as an Adjunctive Treatment to Antidepressant Therapy (ADT) in Patients With Major Depressive Disorder (MDD) Who Have Had an Inadequate Response to Antidepressants Alone — Completed